Nuo Therapeutics Stock Price, News & Analysis (OTCMKTS:NUOTQ) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nuo Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.01 0.00 (0.00 %) (As of 05/11/2016) Add Today's Range$0.01Now: $0.01▼$0.0150-Day Range N/A52-Week Range$0.00Now: $0.01▼$0.29VolumeN/AAverage Volume304,122 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nuo Therapeutics, Inc., formerly Cytomedix, Inc., is a regenerative therapies company developing and marketing products within the United States and internationally through its strategic partners. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's commercial offerings are centered on its point of care platform technologies for the separation of blood and bone marrow to produce platelet based therapies or cell concentrates. It is promoting two distinct platelet rich plasma (PRP) technologies: the Aurix System for wound care, and the Angel concentrated Platelet Rich Plasma (cPRP) System for orthopedics and cardiovascular markets. The Company is focused on developing product candidates utilizing the Bright Cell technology platform, owned by its subsidiary, Aldagen, Inc. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:NUOTQ Previous SymbolOTCMKTS:CMXI CUSIPN/A CIKN/A Webhttp://www.cytomedix.com/ Phone+1-240-4992680Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive NUOTQ News and Ratings via Email Sign-up to receive the latest news and ratings for NUOTQ and its competitors with MarketBeat's FREE daily newsletter. Nuo Therapeutics (OTCMKTS:NUOTQ) Frequently Asked Questions What is Nuo Therapeutics' stock symbol? Nuo Therapeutics trades on the OTCMKTS under the ticker symbol "NUOTQ." Has Nuo Therapeutics been receiving favorable news coverage? News coverage about NUOTQ stock has trended neutral recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nuo Therapeutics earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Nuo Therapeutics. Who are Nuo Therapeutics' key executives? Nuo Therapeutics' management team includes the folowing people: David Emerson Jorden CPA, Chief Executive Officer, Chief Financial Officer, Director (Age 52)Peter A. Clausen Ph.D., Chief Science Officer (Age 49)Shaun C Martin, Chief Restructuring OfficerLawrence Atinsky, DirectorPaul D. Mintz M.D., DirectorLyle A. Hohnke Ph.D., Independent Director (Age 72)Mark T. McLoughlin, Independent Director (Age 61)C. Eric Winzer, Independent Director (Age 58) What is Nuo Therapeutics' stock price today? One share of NUOTQ stock can currently be purchased for approximately $0.01. What is Nuo Therapeutics' official website? The official website for Nuo Therapeutics is http://www.cytomedix.com/. How can I contact Nuo Therapeutics? Nuo Therapeutics' mailing address is 207a Perry Pkwy Ste 1, GAITHERSBURG, MD 20877-2196, United States. The company can be reached via phone at +1-240-4992680. MarketBeat Community Rating for Nuo Therapeutics (OTCMKTS NUOTQ)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 60 (Vote Outperform)Underperform Votes: 45 (Vote Underperform)Total Votes: 105MarketBeat's community ratings are surveys of what our community members think about Nuo Therapeutics and other stocks. Vote "Outperform" if you believe NUOTQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUOTQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/18/2019 by MarketBeat.com StaffFeatured Article: What is the Stochastic Momentum Index (SMI)?